Alzheimer s & Dementia· 2016Q1
Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early‐stage biomarker discovery
- 433citations
- Q1SCImago
- 2016year
Short summary
Locus coeruleus (LC) volume decreases by 8.4% per Braak stage increase in Alzheimer's disease (AD), with neuronal loss only appearing midway through progression.
AI-generated from the title and abstract; the full text is not read.
Key points
- Locus coeruleus (LC) volume decreases by 8.4% for each Braak stage increase in Alzheimer's disease.
- Significant neuronal loss in the LC is observed only midway through AD progression.
- Age-related changes do not significantly affect LC volume.
- The findings suggest a potential delay between neurofibrillary tangle accumulation and neuronal death in the LC.
AI-generated from the title and abstract; the full text is not read.
Abstract
INTRODUCTION: Alzheimer's disease (AD) progression follows a specific spreading pattern, emphasizing the need to characterize those brain areas that degenerate first. The brainstem's locus coeruleus (LC) is the first area to develop neurofibrillary changes (neurofibrillary tangles [NFTs]). METHODS: The methods include unbiased stereological analyses in human brainstems to estimate LC volume and neuronal population in controls and individuals across all AD stages. RESULTS: As the Braak stage increases by 1 unit, the LC volume decreases by 8.4%. Neuronal loss started only midway through AD progression. Age-related changes spare the LC. DISCUSSION: The long gap between NFT accumulation and neuronal loss suggests that a second trigger may be necessary to induce neuronal death in AD. Imaging studies should determine whether LC volumetry can replicate the stage-wise atrophy observed here and how these changes are specific to AD. LC volumetry may develop into a screening biomarker for selecting high-yield candidates to undergo expensive and less accessible positron emission tomography scans and to monitor AD progression from presymptomatic stages.
The authors' abstract, as published at the source. Alzheimer s & Dementia, 2016 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Applied Mathematics
Applied MathematicsMathematics